Cancer Prevention

The undersigned public health, medical and professional organizations write in strong support of your recent announcement that FDA will issue a proposed rule to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels. Such a standard would generate massive public health benefits, preventing millions of young people from smoking and dramatically reducing the number of people who die from tobacco-caused diseases. We urge you to move forward with this proposal as quickly as possible.

The undersigned organizations write to express our concern that FDA has yet to issue any decisions on applications for marketing orders for menthol-flavored e-cigarettes or e-liquid products. We believe granting any such orders would be inconsistent with the agency’s marketing denial orders for other non-tobacco flavored products and would be harmful to public health, particularly to the health of young people.

Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. Yet, about 1 in 3 adults aged 50 to 75 are not getting tested as recommended. This factsheet discusses the importance of screening for colorectal cancer and what can be done to improve screening in the U.S.